Litcius/Paper detail

Serum Metabolomic Profiling to Reveal Potential Biomarkers for the Diagnosis of Fatty Liver Hemorrhagic Syndrome in Laying Hens

Lianying Guo, Jun Kuang, Yu Zhuang, Jialin Jiang, Yan Shi, Cheng Huang, Changming Zhou, Puzhi Xu, Ping Liu, Cong Wu, Guoliang Hu, Xiaoquan Guo

2021Frontiers in Physiology30 citationsDOIOpen Access PDF

Abstract

Fatty liver hemorrhage syndrome (FLHS), a nutritional and metabolic disease that frequently occurs in laying hens, causes serious losses to the poultry industry. Nowadays, the traditional clinical diagnosis of FLHS still has its limitations. Therefore, searching for some metabolic biomarkers and elucidating the metabolic pathway in vivo are useful for the diagnosis and prevention of FLHS. In the present study, a model of FLHS in laying hens induced by feeding a high-energy, low-protein diet was established. Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) was used to analyze the metabolites in serum at days 40 and 80. The result showed that, in total, 40 differential metabolites closely related to the occurrence and development of FLHS were screened and identified, which were mainly associated with lipid metabolism, amino acid metabolism, and energy metabolism pathway disorders. Further investigation of differential metabolites showed 10 potential biomarkers such as 3-hydroxybutyric acid, oleic acid, palmitoleic acid, and glutamate were possessed of high diagnostic values by analyzing receiver operating characteristic (ROC) curves. In conclusion, this study showed that the metabolomic method based on GC-TOF-MS can be used in the clinical diagnosis of FLHS in laying hens and provide potential biomarkers for early risk evaluation of FLHS and further insights into FLHS development.

Topics & Concepts

Palmitoleic acidMetabolomicsLipid metabolismOleic acidFatty liverBiologyMedicineInternal medicinePhysiologyFatty acidBiochemistryDiseaseBioinformaticsLinoleic acidMetabolomics and Mass Spectrometry StudiesLiver Disease Diagnosis and TreatmentPeroxisome Proliferator-Activated Receptors